Surgery News and Research

RSS

Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer

Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment. At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Dr Tim Perren from Leeds Teaching Hospitals NHS Trust, UK, reported findings from the international ICON7 trial, which included 1528 women with high-risk early or advanced stage epithelial ovarian cancer, primary peritoneal cancer or Fallopian tube cancer.

11 Oct 2010

New technologies and surgical techniques promise 'personalized' orthopedic operations

A number of new technologies and surgical techniques promise to "personalize" orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During "Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies," prominent orthopedic researchers will discuss how innovative technologies can improve surgical outcomes.

11 Oct 2010

Upward trend for post-breast feeding breast augmentation procedures

The Harley Medical Group, Ireland's leading cosmetic surgery provider, has revealed breast surgery is top of the ops for the 23rd year running and the fastest growing sector of cosmetic surgery. The Harley Medical Group has seen a positive increase on last year's enquiries. While breast reductions are becoming more popular with an increasing number of Irish women reducing their breast size in order to achieve a more slender figure, breast augmentation continues to be the most popular procedure performed at THMG's Dublin clinic.

11 Oct 2010

IRIDEX introduces new family of Adjustable & Intuitive EndoProbe laser handpieces

IRIDEX Corporation today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company's laser platforms in vitreoretinal surgery.

11 Oct 2010

Class action lawsuit against DePuy Orthopaedics

The preeminent law office of Nurenberg, Paris, Heller & McCarthy has filed a class action lawsuit against Johnson & Johnson's artificial joint replacement company DePuy Orthopaedics, Inc., on behalf of clients who suffered damages resulting from the company's now-recalled hip replacement device. (Case No. 1:10CV02222, U.S. District Court, Northern District of Ohio, Eastern Division)

11 Oct 2010

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Leading national researchers in the fight against breast cancer will convene Oct. 26-29 for the 2010 Advances in Breast Cancer Research Workshop at the University of Arkansas. More than 70 scientists from diverse research areas in science, medicine, engineering and technology will participate. Ten featured speakers will present cutting-edge research on breast cancer diagnosis, therapeutic techniques, treatment and screening.

11 Oct 2010

Novel hormonal treatments may help ER-negative breast cancer patients: Study

Women who have estrogen (ER) negative breast cancer may have more drug treatment options than previously thought, a Creighton (pronounced Cray-ton) University study suggests. The study is reported in the Oct. 11 online version of the journal Oncogene.

11 Oct 2010

OXiGENE announces ZYBRESTAT Phase 2/3 study results at ESMO Congress

OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.

11 Oct 2010

$Balloon kyphoplasty offers effective relief for debilitating spinal fractures suffered by metastatic cancer patients$

Balloon kyphoplasty offers effective relief for debilitating spinal fractures suffered by metastatic cancer patients

A surgical technique appears to offer quick and effective relief for debilitating spinal fractures often suffered by patients with metastatic cancer, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan.

11 Oct 2010

United Recovery Systems donates to Texas Children's Hospital

Employees of United Recovery Systems, LP, a leading account receivables management company, made a charitable contribution to Texas Children's Hospital, one of the top 10 pediatric hospitals in the country.

11 Oct 2010

DTC genetic tests require innovative approach to enter global market

Direct-to-consumer (DTC) genetic tests available from retailers and the Internet let people learn about their genomes without going to a doctor, but they raise the question of who is responsible for oversight and regulation of these tests. Critics worry about safety risks if consumers base important lifestyle or medical decisions on inaccurate or misunderstood test results.

11 Oct 2010

Drugs may prevent temporary combativeness in children after surgery

Temporary combativeness after surgery-a complication affecting up to half of anesthetized children-may be preventable with drugs that decrease epinephrine production, according to a Medical College of Georgia pediatric anesthesiologist.

11 Oct 2010

FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients

Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS) as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval.

11 Oct 2010

Weight loss pill off shelves due to heart attack risk

Final verdict on a popular weight loss drug Reductil is to be delivered today. It is being debated whether the pill should be taken off the shelves in Australia and New Zealand. The drug Sibutramine sold as Reductil is linked to increased risk of heart attacks.

10 Oct 2010

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Integra LifeSciences Holdings Corporation announced today that it is featuring the Inforce Reinforcement Matrix at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Boston, Massachusetts.

8 Oct 2010

Japanese MHLW approves CryoLife's BioGlue Surgical Adhesive for aortic dissections

CryoLife, Inc. an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for use in the repair of aortic dissections.

8 Oct 2010

People involved in ATV crashes are more likely to die from serious trauma: Research

In research that may surprise off-road riding enthusiasts and safety experts, a Johns Hopkins team has found that crashes involving ATVs four-wheeled all-terrain vehicles — are significantly more dangerous than crashes involving two-wheeled off-road motorcycles, such as those used in extreme sports like Motocross.

8 Oct 2010

HHS, PEPFAR to invest $130 million to transform African medical education

The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) to invest $130 million over five years to transform African medical education and dramatically increase the number of practicing health care workers.

8 Oct 2010

Portrait painting may help children with craniofacial problems

A group of artists, young people and medical experts are involved in a groundbreaking project at The Children's Hospital of Philadelphia that uses the intimate process of portrait painting to help children and young people with craniofacial problems see themselves in a different light.

8 Oct 2010

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department's Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company's flagship StrataGraft living human skin substitute tissue.

8 Oct 2010

Surgery News and Research

Research suggests bevacizumab delays progression in newly diagnosed ovarian cancer

New technologies and surgical techniques promise 'personalized' orthopedic operations

Upward trend for post-breast feeding breast augmentation procedures

IRIDEX introduces new family of Adjustable & Intuitive EndoProbe laser handpieces

Class action lawsuit against DePuy Orthopaedics

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Novel hormonal treatments may help ER-negative breast cancer patients: Study

OXiGENE announces ZYBRESTAT Phase 2/3 study results at ESMO Congress

Balloon kyphoplasty offers effective relief for debilitating spinal fractures suffered by metastatic cancer patients

United Recovery Systems donates to Texas Children's Hospital

DTC genetic tests require innovative approach to enter global market

Drugs may prevent temporary combativeness in children after surgery

FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients

Weight loss pill off shelves due to heart attack risk

Integra LifeSciences to feature Inforce Reinforcement Matrix at ASSH Annual Meeting

Japanese MHLW approves CryoLife's BioGlue Surgical Adhesive for aortic dissections

People involved in ATV crashes are more likely to die from serious trauma: Research

HHS, PEPFAR to invest $130 million to transform African medical education

Portrait painting may help children with craniofacial problems

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News